Asthma Monitoring Device- Methacholine Challenge Study

  • Research type

    Research Study

  • Full title

    Detection of Methacholine Challenge Induced Asthma Symptoms Using a Novel Device

  • IRAS ID

    212494

  • Contact name

    Lee Brooks

  • Contact email

    lee.brooks@anaxsys.com

  • Sponsor organisation

    Anaxsys Technology Ltd

  • Duration of Study in the UK

    0 years, 4 months, 26 days

  • Research summary

    Is the Anaxsys Asthma Monitoring Device able to detect asthma symptoms in known asthmatics?
    Anaxsys is developing a device to monitor asthma symptoms. It will be used by asthma sufferers to help them control their condition. This device will be an alternative to the peak flow meter. The investigational device is a prototype.
    Between eight and twenty adults with asthma will take part in a Methacholine challenge test. A Methacholine challenge test measures how sensitive a person is to things that commonly cause asthma symptoms. The patient breathes in a substance called methacholine to see how sensitive their lungs are. To begin the test the patient breathes in a small amount of Methacholine. Their Lung function (how well their lungs work) is then measured using a spirometer. A spirometer is a device which accurately measures lung function. More Methacholine is then breathed in and their lung function measured again. This carries on until they start to have asthma symptoms. The asthma symptoms are then quickly reversed by breathing in a type of drug known as a bronchodilator (salbutamol inhaler). Their lung function is then measured again using a spirometer.
    The Methacholine challenge tests in this study will be performed in a single visit of around four hours for each patient. It will take place at the Leicester Respiratory Biomedical Research Unit. Trained healthcare specialists will be in charge of the testing.
    The lung function of each patient will be measured using the Anaxsys device after each test with the spirometer. If the spirometer shows that a patient’s lungs are not working as well as they did before the testing started the Anaxsys device must show the same thing.

  • REC name

    East of England - Cambridge Central Research Ethics Committee

  • REC reference

    16/EE/0372

  • Date of REC Opinion

    6 Oct 2016

  • REC opinion

    Further Information Favourable Opinion